FK-506 is a
**Core Concept**
FK-506, also known as Tacrolimus, is a calcineurin inhibitor that plays a crucial role in immunosuppression by inhibiting the activation of T-lymphocytes. This mechanism is essential in preventing organ rejection in transplant patients.
**Why the Correct Answer is Right**
FK-506 binds to FK Binding Protein 12 (FKBP-12), a cytosolic protein, forming a complex that inhibits calcineurin, a phosphatase responsible for dephosphorylating and activating Nuclear Factor of Activated T-cells (NFAT). This inhibition prevents the translocation of NFAT to the nucleus, thereby blocking the transcription of IL-2, a key cytokine involved in T-cell activation and proliferation.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because FK-506 is not a monoclonal antibody, which is a different class of immunosuppressants.
**Option B:** Incorrect because FK-506 does not work by inhibiting the enzyme mTOR, which is involved in cell growth and proliferation.
**Option C:** Incorrect because FK-506 is not a corticosteroid, which is a different class of immunosuppressants.
**Clinical Pearl / High-Yield Fact**
FK-506 is commonly used in conjunction with other immunosuppressants, such as cyclosporine, to prevent organ rejection in transplant patients. However, its use is associated with nephrotoxicity and neurotoxicity, which can be dose-limiting.
**Correct Answer:** D.